strongly recommend against adding oral or IV BP, PTH/PTHrP, RAL, DEN, or ROM (PICO 1.4a-1.28a). Adults <40 years have low fracture risk and have significant capacity to rebuild BMD losses induced by chronic GC therapy. OP therapy should not be started in this low-risk group Recommendations for special populations of patients beginning long-term GC therapy at very high risk for fracture (Table 2 For adults â‰¥40 years at very high fracture risk due to treatment with one or more courses of